ELAN - Fur-casting Success: Elanco Animal Health Tails Ahead with Raised Revenue Outlook Stock Soars | Benzinga

Elanco Animal Health Inc (NYSE: ELAN) reported a Q3 FY23 revenue of $1.068 billion, up 4% reported growth or 5% excluding the impact of foreign exchange rates, above the consensus of $1.04 billion. The management expected Q3 revenues of $1.03-$1.06 billion. 

Adjusted EPS of $0.18, up from $0.17 reported a year ago, surpassing the management guidance of $0.08-$0.13 and analysts' view of $0.12.

Pet Health's revenue increased by 6% to $495 million, with a 4% increase in price. Farm Animal revenue Full story available on Benzinga.com